Glycosphingolipids Amphiceramide A and B
glycolipids. This fraction was peracetylated with Ac2O in pyridine
for 12 h. The acetylated glycolipids were subjected to HPLC sepa-
ration on an SiO2 column [eluent: n-hexane/EtOAc (6:4)]. Five
major fractions were obtained, each mainly composed of one of
the compounds 1b–5b. Axiceramide A (1b, 5.6 mg) and B (2b,
1.6 mg) were obtained in pure form from the corresponding frac-
tions after a further normal-phase HPLC purification [eluent: n-
hexane/iPrOH (85:15)] followed by reversed-phase HPLC (eluent:
MeOH). Fractions containing compounds 3b–5b were homogen-
eous as far as the polar parts of the molecules are concerned, and
3.5 Hz, 1 H, 1-Hb), 4.53 (q, J = 8.7 Hz, 1 H, 2ЈЈ-H), 4.57 (m, 1 H,
2ЈЈЈ-H), 4.75 (overlapped, 1-Ha), 4.75 (overlapped, 6Ј-Ha), 4.85 (d,
J = 7.7 Hz, 1 H, 1Ј-H), 5.25 (d, J = 8.3 Hz, 1 H, 1ЈЈ-H), 5.27
(overlapped, 1 H, 2-H), 5.70 (ddd, J = 15.2, 6.9, 6.9 Hz, 1 H, 7-H),
5.97 (ddd, J = 15.2, 6.9, 6.9 Hz, 1 H, 6-H), 8.55 (d, J = 8.9 Hz, 1
H, 2-NH), 8.92 (d, J = 7.5 Hz, 1 H, 2ЈЈ-NH) ppm. 13C NMR
(C5D5N): δ = 14.3 (CH3, C-18, C-22ЈЈЈ), 23.0 (CH2, C-17, C-21ЈЈЈ),
23.4 (CH3, acetyl Me), 25.9 (CH2, C-4ЈЈЈ), 29.7–30.3 (several CH2,
alkyl chain methylene groups), 32.1 (CH2, C-16, C-20ЈЈЈ), 33.2
(CH2, C-8), 35.5 (CH2, C-3ЈЈЈ), 37.7 (CH2, C-5), 51.6 (CH, C-2),
therefore reversed-phase HPLC (eluent: MeOH) was sufficient to 58.1 (CH, C-2ЈЈ), 62.7 (CH2, C-6ЈЈ), 70.1 (CH2, C-6Ј), 70.3 (CH2,
separate them from their minor homologues, the new molecular
species 3b (81 mg) and known compounds 4b (33 mg) and 5b
(8.8 mg).
C-1), 71.8 (CH, C-4Ј), 72.5 (CH, C-4ЈЈ), 72.5 (CH, C-2ЈЈЈ), 72.9
(CH, C-4), 75.2 (CH, C-2Ј), 75.6 (CH, C-3), 76.7 (CH, C-3ЈЈ), 77.3
(CH, C-5Ј), 78.4 (CH, C-3Ј), 78.6 (CH, C-5ЈЈ), 103.2 (CH, C-1ЈЈ),
105.3 (CH, C-1Ј), 128.4 (CH, C-6), 133.0 (CH, C-7), 171.2 (C, ace-
tyl CO), 175.7 (C, C-1ЈЈЈ) ppm.
Amphiceramide A Peracetate (1b): Amorphous solid. [α]2D5 = +2 (c
= 1.5, CHCl3). MS (ESI, positive ion mode, MeOH): m/z = 1419
1
[M + Na]+. For H and 13C NMR data, see Table 1.
Amphiceramide B (2a): Colorless solid. [α]2D5 = –7 (c = 0.5, CHCl3).
HRMS (ESI, positive ion mode, MeOH): m/z = 1000.6931 [M +
Amphiceramide B Peracetate (2b): Amorphous solid. [α]2D5 = +4 (c
= 0.5, CHCl3). MS (ESI, positive ion mode, MeOH): m/z = 1420
Na]+ (calcd. for C52H99NNaO15 1000.6907). H NMR (C5D5N):
δ = 0.85 (2 overlapping t, J = 6.7 Hz, 6 H, 18-H3 and 22ЈЈЈ-H3),
1.27 (alkyl chain methylene protons), 1.75 (m, 1 H, 4ЈЈЈ-Hb), 1.67
(m, 1 H, 4ЈЈЈ-Ha), 1.97 (m, 1 H, 3ЈЈЈ-Hb), 2.03 (m, 2-H, 8-H2), 2.18
(m, 1 H, 3ЈЈЈ-Ha), 2.69 (m, 1 H, 5-Hb), 3.02 (m, 1 H, 5-Ha), 3.91
(m, 1 H, 2Ј-H), 3.95 (m, 1 H, 5Ј-H), 4.06 (overlapped, 5ЈЈ-H), 4.08
(overlapped, 4Ј-H), 4.10 (overlapped, 3Ј-H), 4.17 (m, 1 H, 3ЈЈ-H),
4.25 (dd, J = 11.3, 6.1 Hz, 1 H, 6Ј-Hb), 4.28 (overlapped, 4-H),
4.35 (m, 1 H, 3-H), 4.41 (overlapped, 6ЈЈ-H2), 4.43 (overlapped, 1-
Hb), 4.49 (t, J = 8.3 Hz, 1 H, 2ЈЈ-H), 4.53 (br. s, 1 H, 4ЈЈ-H), 4.58
(m, 1 H, 2ЈЈЈ-H), 4.75 (dd, J = 10.7, 5.9 Hz, 1 H, 1-Ha), 4.81 (br.
d, J = 11.3 Hz, 1 H, 6Ј-Ha), 4.85 (d, J = 7.9 Hz, 1 H, 1Ј-H), 4.99
(d, J = 7.8 Hz, 1 H, 1ЈЈ-H), 5.26 (overlapped, 2-H), 5.71 (ddd, J =
15.1, 6.7, 6.7 Hz, 1 H, 7-H), 5.98 (ddd, J = 15.1, 6.9, 6.9 Hz, 1 H,
6-H), 8.57 (d, J = 9.3 Hz, 1 H, 2-NH) ppm. 13C NMR (C5D5N): δ
= 14.3 (CH3, C-18, C-22ЈЈЈ), 22.9 (CH2, C-17, C-21ЈЈЈ), 29.7–30.3
(several CH2, alkyl chain methylene groups), 32.2 (CH2, C-16, C-
20ЈЈЈ), 33.2 (CH2, C-8), 35.5 (CH2, C-3ЈЈЈ), 37.3 (CH2, C-5), 51.3
(CH, C-2), 62.4 (CH2, C-6ЈЈ), 69.8 (CH2, C-6Ј), 70.2 (CH, C-4ЈЈ),
70.5 (CH2, C-1), 71.4 (CH, C-4Ј), 72.3 (CH, C-2ЈЈЈ), 72.6 (CH, C-
2ЈЈ), 72.6 (CH, C-4), 74.9 (CH, C-2Ј), 75.1 (CH, C-3ЈЈ), 75.3 (CH,
C-3), 76.9 (CH, C-5ЈЈ), 77.1 (CH, C-5Ј), 78.2 (CH, C-3Ј), 105.3
(CH, C-1Ј), 105.8 (CH, C-1ЈЈ), 128.2 (CH, C-6), 132.7 (CH, C-7),
175.7 (C, C-1ЈЈЈ) ppm.
+
1
1
[M + Na]+. For H and 13C NMR data, see Table 1.
Compound 3b: Amorphous solid. MS (ESI, positive ion mode,
1
MeOH): m/z = 1131 [M + Na]+. H NMR (CDCl3): δ = 0.88 (t, J
= 6.7 Hz, 6 H, 18-H3 and 22ЈЈЈ-H3), 1.28 (alkyl chain methylene
protons), 1.92 (s, 3 H, N-acetyl Me group), 1.93 (overlapped, 8-
H2), 1.99–2.19 (6 s, 18 H, O-acetyl Me groups), 2.22 (overlapped,
1 H, 5-Hb), 2.34 (m, 1 H, 5-Ha), 3.46 (m, 1 H, 2Ј-H), 3.72 (over-
lapped, 1-H2), 3.72 (overlapped, 5Ј-H), 4.10 (br. d, J = 12.4 Hz, 1
H, 6Ј-Hb), 4.24 (dd, J = 12.4, 4.1 Hz, 1 H, 6Ј-Ha), 4.30 (m, 1 H,
2-H), 4.85 (d, J = 8.2 Hz, 1 H, 1Ј-H), 4.95 (overlapped, 2 H, 3-H,
4-H), 5.00 (t, J = 9.6 Hz, 1 H, 4Ј-H), 5.07 (dd, J = 4.5, 7.3 Hz, 1
H, 2ЈЈ-H), 5.23 (ddd, J = 15.2, 6.9, 6.9 Hz, 1 H, 6-H), 5.37 (t, J =
9.6 Hz, 1 H, 3Ј-H), 5.44 (ddd, J = 15.2, 6.9, 6.9 Hz, 1 H, 7-H), 6.07
(d, J = 8.6 Hz, 1 H, 2Ј-NH), 7.10 (d, J = 8.6 Hz, 1 H, 2-NH) ppm.
13C NMR (CDCl3): δ = 14.2 (CH3, C-18, C-22ЈЈ), 20.5–23.2 (sev-
eral CH3, acetyl Me groups), 22.7–31.8 (several CH2, alkyl chain
methylene groups), 32.7 (CH2, C-5), 32.7 (CH2, C-8), 47.8 (CH, C-
2), 55.5 (CH, C-2Ј), 61.9 (CH2, C-6Ј), 66.2 (CH2, C-1), 68.8 (CH,
C-4Ј), 71.9 (CH, C-5Ј), 72.2 (CH, C-3Ј), 72.6 (CH, C-4), 72.6 (CH,
C-3), 98.9 (CH, C-1Ј), 123.7 (CH, C-6), 134.7 (CH, C-7), 170.1 (C,
C-1ЈЈ), 171.2 (C, N-acetyl CO group), 169.6–177.1 (several C, O-
acetyl CO groups) ppm.
Deacetylation of Compounds 1b–4b: Compounds 1b–4b were each
dissolved in MeOH (1 mL), and a solution of MeONa in MeOH
(0.4 , 50 µL) was added. The reactions were carried out at 25 °C
for 18 h, and then the reaction mixtures were dried under nitrogen
and the residues partitioned between water and chloroform. After
removal of the solvent, the organic layers gave the corresponding
native glycosphingolipids 1a (1.5 mg), 2a (0.9 mg), 3a (11.3 mg), 4a
(2.8 mg), and 5a (5.7 mg).
Compound 3a: White solid. MS (ESI, positive ion mode, 1 m LiCl
1
in MeOH): m/z = 863 [M + Li]+. H NMR (C5D5N): δ = 0.86 (2
overlapping t, J = 6.7 Hz, 6 H, 18-H3, 22ЈЈЈ-H3), 1.27 (alkyl chain
methylene protons), 1.75 (m, 1 H, 4ЈЈЈ-Hb), 1.67 (m, 1 H, 4ЈЈЈ-Ha),
1.97 (m, 1 H, 3ЈЈ-Ha), 2.02 (m, 2 H, 8-H2), 2.17 (s, 3 H, Ac), 2.18
(overlapped, 3ЈЈ-Hb), 2.67 (m, 1 H, 5-Hb), 3.00 (m, 1 H, 5-Ha),
3.82 (m, 1 H, 5Ј-H), 4.18 (t, J = 9.2 Hz, 1 H, 4Ј-H), 4.23 (over-
lapped, 4-H), 4.24 (overlapped, 3Ј-H), 4.29 (overlapped, 6Ј-Hb),
4.29 (overlapped, 3-H), 4.44 (m, 1 H, 6Ј-Ha), 4.48 (m, 1 H, 2Ј-H),
4.54 (dd, J = 10.9, 3.9 Hz, 1 H, 1-Hb), 4.59 (overlapped, 1-Ha),
4.59 (overlapped, 2ЈЈ-H), 5.12 (d, J = 8.3 Hz, 1 H, 1Ј-H), 5.24 (m,
1 H, 2-H), 5.70 (ddd, J = 15.2, 6.6, 6.6 Hz, 1 H, 7-H), 5.94 (ddd,
J = 15.2, 6.8, 6.8 Hz, 1 H, 6-H), 8.5 (d, J = 9.3 Hz, 1 H, 2Ј-NH),
8.85 (d, J = 7.7 Hz, 1 H, 2-NH) ppm. 13C NMR (C5D5N): δ = 14.3
(CH3, C-18, C-22ЈЈЈ), 23.0 (CH2, C-17, C-21ЈЈЈ), 23.4 (CH3, acetyl
Me), 25.9 (CH2, C-4ЈЈЈ), 29.7–30.3 (several CH2, alkyl chain meth-
Amphiceramide A (1a): Colorless solid. [α]2D5 = –4 (c = 0.9, CHCl3).
HRMS (ESI, positive ion mode, MeOH): m/z = 1041.7183 [M +
Na]+ (calcd. for C54H102N2NaO15+ 1041.7172). 1H NMR (C5D5N):
δ = 0.86 (2 overlapping t, J = 6.7 Hz, 6 H, 18-H3, 22ЈЈЈ-H3), 1.27
(alkyl chain methylene protons), 1.75 (m, 1 H, 4ЈЈЈ-Hb), 1.67 (m, 1
H, 4ЈЈЈ-Ha), 1.94 (m, 1 H, 3ЈЈЈ-Hb), 2.03 (m, 2 H, 8-H2), 2.17 (s, 3
H, Ac), 2.18 (overlapped, 3ЈЈЈ-Ha), 2.68 (m, 1 H, 5-Hb), 3.02 (m,
1 H, 5-Ha), 3.91 (overlapped, 5ЈЈ-H), 3.93 (overlapped, 4Ј-H), 3.94
(overlapped, 2Ј-H), 3.95 (overlapped, 5Ј-H), 4.11 (m, 1 H, 3Ј-H), ylene groups), 32.1 (CH2, C-16, C-20ЈЈЈ), 33.2 (CH2, C-8), 35.5
4.14 (dd, J = 11.2, 6.3 Hz, 1 H, 6Ј-Hb), 4.21 (m, 1 H, 4ЈЈ-H), 4.28 (CH2, C-3ЈЈЈ), 37.7 (CH2, C-5), 50.6 (CH, C-2), 57.8 (CH, C-2Ј),
(m, 1 H, 4-H), 4.32 (overlapped, 6ЈЈ-Hb), 4.33 (overlapped, 3-H),
4.40 (m, 1 H, 3ЈЈ-H), 4.47 (m, 1 H, 6ЈЈ-Ha), 4.50 (dd, J = 10.3,
62.4 (CH2, C-6Ј), 69.0 (CH2, C-1), 72.3 (CH, C-4Ј), 72.6 (CH, C-
2ЈЈ), 72.8 (CH, C-3Ј), 75.4 (CH, C-3), 77.1 (CH, C-4), 78.5 (CH,
Eur. J. Org. Chem. 2009, 2112–2119
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2117